Literature DB >> 12453976

Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect.

Tomasz Klupa1, James H Warram, Anthony Antonellis, Marcus Pezzolesi, Moonsuk Nam, Maciej T Malecki, Alessandro Doria, Stephen S Rich, Andrzej S Krolewski.   

Abstract

OBJECTIVE: To determine the distribution of the age at onset of diabetes (maturity-onset diabetes of the young-3 [MODY3]) and to identify determinants of the onset of diabetes in carriers of HNF-1alpha mutations. RESEARCH DESIGN AND METHODS: Extended families (n = 104) with type 2 diabetes inherited in a dominant pattern were recruited and screened for diabetes-causing mutations in HNF-1alpha.
RESULTS: HNF-1alpha mutations cosegregated with diabetes in only 13 families, all with a mean age at onset <35 years. Insulin secretion was diminished or absent in mutation carriers (n = 101), and diabetes developed in 65% by age 25 years and in 100% by age 50 years. If the mutation was inherited from the mother, diabetes onset was very young in those exposed to diabetes in utero; 57 +/- 8% were affected by age 15 years as compared with 0.0% in those not exposed (P < 7 x 10(-6)). By age 25 years, the difference was reduced (85 +/- 6 and 55 +/- 12%, respectively; P = 0.02). If the mutation was inherited from the father, diabetes developed in 52 +/- 8% by age 25 years. Age at diagnosis was shown to be highly heritable (h(2) = 0.47, P = 0.003). When parent of origin was included in the analyses, the magnitude of genetic contribution increased markedly (h(2) = 0.91).
CONCLUSIONS: Mutations in HNF-1alpha accounts for diabetes in a small proportion of families with a dominant pattern of inheritance. Age at onset of diabetes in MODY3 families varied widely and was influenced by familial factors (including modifying genes) and parent of origin (whether a mutation carrier was exposed to diabetes in utero).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453976     DOI: 10.2337/diacare.25.12.2292

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

1.  Genomic imprinting in diabetes.

Authors:  Braxton D Mitchell; Toni I Pollin
Journal:  Genome Med       Date:  2010-08-23       Impact factor: 11.117

2.  Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction.

Authors:  Maciej Borowiec; Chong W Liew; Ryan Thompson; Watip Boonyasrisawat; Jiang Hu; Wojciech M Mlynarski; Ilham El Khattabi; Sung-Hoon Kim; Lorella Marselli; Stephen S Rich; Andrzej S Krolewski; Susan Bonner-Weir; Arun Sharma; Michele Sale; Josyf C Mychaleckyj; Rohit N Kulkarni; Alessandro Doria
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer.

Authors:  B Liljeström; K Aktan-Collan; B Isomaa; L Sarelin; A Uutela; L Groop; H Kääriäinen; T Tuomi
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

Review 4.  Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.

Authors:  J R Porter; T G Barrett
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

5.  Molecular diagnosis of maturity onset diabetes of the young in Iranian patients: improving management.

Authors:  Fatemeh Davoudi; Majid Aminzadeh; Hajiye Bibi Shahbazian; Mahdi Bijanzadeh; Ata A Ghadiri; Pegah Ghandil
Journal:  J Diabetes Metab Disord       Date:  2021-08-19

Review 6.  The Genetic Architecture of Diabetes in Pregnancy: Implications for Clinical Practice.

Authors:  Jeffrey W Kleinberger; Kristin A Maloney; Toni I Pollin
Journal:  Am J Perinatol       Date:  2016-08-29       Impact factor: 1.862

Review 7.  Investigating parent of origin effects in studies of type 2 diabetes and obesity.

Authors:  Evadnie Rampersaud; Braxton D Mitchell; Adam C Naj; Toni I Pollin
Journal:  Curr Diabetes Rev       Date:  2008-11

8.  Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young.

Authors:  Abdelhadi M Habeb; Elizabeth T George; Verghese Mathew; Andrew L Hattersley
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

9.  Family-based association analysis confirms the role of the chromosome 9q21.32 locus in the susceptibility of diabetic nephropathy.

Authors:  Marcus G Pezzolesi; Jackson Jeong; Adam M Smiles; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

10.  Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes.

Authors:  Hana Lango Allen; Stefan Johansson; Sian Ellard; Beverley Shields; Jens K Hertel; Helge Raeder; Kevin Colclough; Anders Molven; Timothy M Frayling; Pål R Njølstad; Andrew T Hattersley; Michael N Weedon
Journal:  Diabetes       Date:  2009-09-30       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.